Same Indication

Dabigatran vs Montelukast

Dabigatran vs Montelukast: Overview

This comparison examines the pharmacological differences between Dabigatran and Montelukast.

Mechanism of Action

Dabigatran: Direct thrombin (Factor IIa) inhibitor.

Montelukast: Selective leukotriene D4 receptor antagonist.

Pharmacokinetics

Half-life: Dabigatran β€” 12-17 hours; Montelukast β€” 2.7-5.5 hours.

Chemical Properties

Molecular Formula: Dabigatran β€” C25H25N7O3; Montelukast β€” C35H36ClNO3S.

Molecular Weight: Dabigatran β€” 471.5100 g/mol; Montelukast β€” 586.1800 g/mol.

Type: Dabigatran β€” Small molecule; Montelukast β€” Small molecule.